S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

QNRX Quoin Pharmaceuticals Ltd

0.3198

-0.0002 (-0.06%)

Jan 29 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals Ltd News

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 28 January 2025 (1 day ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 January 2025 (6 days ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
Thursday 23 January 2025 (7 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 16 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Tuesday 14 January 2025 (2 weeks ago) • GlobeNewswire Inc.

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 6 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study
Monday 6 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Thursday 2 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Thursday 2 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (1 month ago) • Edgar (US Regulatory)

More Quoin Pharmaceuticals Ltd News Articles

Green Leaf Innovations (PK)

Voip Pal Com (QB)

NioCorp Developments

GBT Technologies (PK)

Clean Vision (QB)

AMC Entertainment

Valiant Eagle (PK)

UAV Corpoation (PK)

RespireRx Pharmaceuticals (CE)

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

Moon Equity (PK)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions